Search
for
Sort by
Research 421–450 of 421
- Improved Poly (D,L‐lactide) nanoparticles‐based formulation for hair follicle targeting
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- FDA approves label addition for PDE-5 inhibitor
- 467 Novel selective phosphodiesterase inhibitors promote the adipogenic function of dermal fibroblasts: Implication to treat hair loss
- Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase‐4 inhibitors
- Adverse effects of common medications on male fertility
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Organic Causes of Erectile Dysfunction in Men Under 40
- Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses
- Smoke water promotes root meristem activity and cell elongation but inhibits root hair growth under phosphorus deficiency in rice
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Aromatase inhibitor–induced hair loss in two adolescents
- Cutaneous Toxicities of MEK Inhibitor Use in Children: A Comparison of Binimetinib and Selumetinib
- Perceived Efficacy and Risks of Janus Kinase Inhibitors in Pediatric and Young Adult Alopecia Areata: A Cross‐Sectional Survey
- 1113 Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils via Ly6 antigen for psoriasiform dermatitis alleviation
- Systemic Therapies for Pediatric Alopecia Areata.
- Omeprazole-induced hypertrichosis in two children
- To Treat or Not to Treat: Two Roads Traveled With Alopecia Areata
- Treatment Strategies for Pediatric Trichotillomania: State‐of‐the‐Art Review on Progress and Persistent Challenges
- Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double‐blind, placebo‐controlled trial
- A Phase 1, Open‐Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6–12 Years With Alopecia Areata
- Contemporary drug synthesis
- Exploring the Complexities of Atopic Dermatitis: Pathophysiological Mechanisms and Therapeutic Approaches
- Lower urinary tract symptoms (LUTS): The role of medications in improvement of quality of life
- What is alopecia areata?
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- A novel therapeutic paradigm for patients with extensive alopecia areata